US FDA completes inspection of Lupin's Tarapur facility
Pharma major Lupin Limited announced the completion of the United States Food and Drug Administration (FDA) inspection carried out at its Tarapur manufacturing (API) facility.
The inspection was carried out between September 16 to September 20, 2019, the company said.
The company further added that inspection at the Tarapur facility closed with three observations.
The company is confident of addressing them satisfactorily.
The inspection was carried out between September 16 to September 20, 2019, the company said.
The company further added that inspection at the Tarapur facility closed with three observations.
The company is confident of addressing them satisfactorily.
Comments
Post a Comment